Uppsala Reports editor
@UMCGlobalSafety
Ensuring trust in AI is vital to fully reap the benefits of the technology in pharmacovigilance. Yet, how do we do so while grappling with its ever-growing complexity?
According to Michael Glaser, the Safety Innovation Technology Director at GSK, the answer lies in a mindset shift in how we think about validating AI and machine learning, and coming together to discuss how we move forward in the implementation of this technology in healthcare.
This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. Subscribe by visiting the Drug Safety Matters website.
Uppsala Reports editor
@UMCGlobalSafety
AI is already reshaping drug safety. Niklas Norén explores how to harness its power responsibly in this two-part episode.
22 October 2025
AI is already reshaping drug safety. Niklas Norén explores how to harness its power responsibly in this two-part episode.
26 November 2025
Patient reporting can surface safety signals sooner, but ADR systems are hard to navigate. Can a consumer-centred, co-designed digital approach make reporting easier?
12 March 2026